SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

CEO-designate update

4 Sep 2017 07:01

RNS Number : 6644P
Victrex PLC
04 September 2017
 

 

 

4 September 2017

Victrex plc

Jakob Sigurdsson joins Victrex as CEO-designate

Victrex plc, an innovative world leader in high performance polymer solutions, is pleased to announce that, further to our announcement of 19 April 2017, Jakob Sigurdsson has started at Victrex as Chief Executive-designate, effective 1 September 2017.

Jakob, 53, will join the Board as Chief Executive on 1 October, succeeding David Hummel who is retiring from the Company after 24 highly successful years as Chief Executive. Dave will work through an orderly transition with Jakob over the coming months, remaining on the Board as an Executive Director until Victrex's AGM in February 2018, before retiring from the Company on 31 March 2018.

Larry Pentz, Chairman of Victrex, said: "I am delighted that Jakob has joined Victrex. With his track record of making markets and delivering growth, the Board believes this appointment is a strong fit for Victrex as we focus on executing our Polymer & Parts strategy over the coming years."

David Hummel, Chief Executive of Victrex, said: "Jakob joins Victrex at a good time for the business. We continue to perform well and are well placed for 2017. I am greatly looking forward to working with Jakob over the coming months."

Jakob Sigurdsson, Chief Executive-designate of Victrex, commented: "It is great to get started and focus on executing our strategy and delivering the attractive growth opportunities that lie ahead."

There are no disclosures under paragraph 9.6.13R (1)-(6) of the Listing Rules.

 

Notes:

Jakob Sigurdsson has more than 20 years' experience in diverse multinational companies, both private and listed, including as the former Chief Executive of Promens in Europe, with Rohm & Haas (now part of Dow Chemical) in the US, and as Chief Executive of food manufacturer Alfesca.

 

 

Enquiries:

 

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications

+44 (0) 1253 898121

 

Louisa Burdett, Group Finance Director

+44 (0) 1253 897700

 

David Hummel, Chief Executive

+44 (0) 1253 897700

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy (including Manufacturing & Engineering), Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we develop world leading solutions in PEEK and PAEK-based polymers, semi-finished and finished parts which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUOUURBAAKRUR
Date   Source Headline
29th May 202611:00 amRNSTotal Voting Rights
18th May 20268:50 amRNSDirectorate change
11th May 20267:00 amRNSHalf-year Financial Report
30th Apr 202610:46 amRNSTotal Voting Rights
29th Apr 20264:28 pmRNSHolding(s) in Company
31st Mar 20261:37 pmRNSTotal Voting Rights
24th Mar 20264:29 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
20th Mar 20269:38 amRNSHolding(s) in Company
27th Feb 20262:40 pmRNSTotal Voting Rights
27th Feb 20261:02 pmRNSHolding(s) in Company
24th Feb 202611:41 amRNSHolding(s) in Company
17th Feb 20263:06 pmRNSDirector/PDMR Shareholding
12th Feb 20263:26 pmRNSDirector/PDMR Shareholding
12th Feb 20263:22 pmRNSDirector/PDMR Shareholding
10th Feb 20262:43 pmRNSDirector/PDMR Shareholding
10th Feb 20269:00 amRNSDirectorate change
6th Feb 20261:33 pmRNSResult of AGM
6th Feb 20267:00 amRNSQ1 Trading Update
30th Jan 202611:49 amRNSTotal Voting Rights
28th Jan 202612:25 pmRNSHolding(s) in Company
22nd Jan 202610:21 amRNSHolding(s) in Company
20th Jan 20261:26 pmRNSAdditional Listing
31st Dec 20259:00 amRNSTotal Voting Rights
31st Dec 20259:00 amRNSTotal Voting Rights
22nd Dec 202512:00 pmRNSAnnual Financial Report
22nd Dec 202512:00 pmRNSAnnual Financial Report
18th Dec 202511:49 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20253:42 pmRNSDirector/PDMR Shareholding
17th Dec 202512:08 pmRNSDirector/PDMR Shareholding
15th Dec 20259:00 amRNSDirector/PDMR Shareholding
11th Dec 20258:52 amRNSDirector/PDMR Shareholding
5th Dec 20259:30 amRNSShare purchase by incoming Director (incoming CEO)
4th Dec 20259:06 amRNSFinancial Calendar Update
2nd Dec 20257:00 amRNSPreliminary Results
1st Dec 202510:49 amRNSBlock listing Interim Review
28th Nov 20259:27 amRNSTotal Voting Rights
20th Nov 20259:05 amRNSAdditional Listing
7th Nov 202510:39 amRNSHolding(s) in Company
31st Oct 20258:58 amRNSTotal Voting Rights
21st Oct 20257:30 amRNSCEO Succession update
3rd Oct 202511:36 amRNSHolding(s) in Company
3rd Oct 20259:03 amRNSHolding(s) in Company
30th Sep 20259:54 amRNSTotal Voting Rights
29th Aug 202510:16 amRNSTotal Voting Rights
31st Jul 20259:14 amRNSTotal Voting Rights
9th Jul 20251:02 pmRNSHolding(s) in Company
8th Jul 20253:33 pmRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSDirectorate change: CEO succession
8th Jul 20257:00 amRNSQ3 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.